On interactions between body mass index, type of anticoagulation and outcomes

Marko Lucijanic¹, Marko Skelin², Ivana Jurin³, Irzal Hadzibegovic⁴

Affiliations

¹ Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia. Electronic address: markolucijanic@yahoo.com.
² Pharmacy Department, General Hospital Sibenik, Ul. Stjepana Radica 83, 22000 Sibenik, Croatia.
³ Cardiology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia.
⁴ Cardiology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia; Faculty of Medicine, University of Osijek, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia.

PMID: 32505328
DOI: 10.1016/j.ijcard.2020.04.064

Comment

On interactions between body mass index, type of anticoagulation and outcomes

Marko Lucijanic et al. Int J Cardiol. 2020.

. 2020 Aug 1:312:107.

doi: 10.1016/j.ijcard.2020.04.064.

Authors

Marko Lucijanic¹, Marko Skelin², Ivana Jurin³, Irzal Hadzibegovic⁴

Affiliations

¹ Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia. Electronic address: markolucijanic@yahoo.com.
² Pharmacy Department, General Hospital Sibenik, Ul. Stjepana Radica 83, 22000 Sibenik, Croatia.
³ Cardiology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia.
⁴ Cardiology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000 Zagreb, Croatia; Faculty of Medicine, University of Osijek, Ul. Josipa Huttlera 4, 31000 Osijek, Croatia.

PMID: 32505328
DOI: 10.1016/j.ijcard.2020.04.064

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest IJ has received speaker honoraria from Boehringer Ingelheim. IH has received speaker honoraria from Boehringer Ingelheim, Pfizer and Bayer. Other authors report no conflict of interest.

Comment on

Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
Lucijanic M, Jurin I, Jurin H, Lucijanic T, Starcevic B, Skelin M, Glasnovic A, Catic J, Jurisic A, Hadzibegovic I. Lucijanic M, et al. Int J Cardiol. 2020 Feb 15;301:90-95. doi: 10.1016/j.ijcard.2019.10.035. Epub 2019 Oct 30. Int J Cardiol. 2020. PMID: 31748190
Moderating effect of obesity on clinical outcomes in NOAC-treated atrial fibrillation patients or just an effect of obesity?
Trkulja V. Trkulja V. Int J Cardiol. 2020 Aug 1;312:109. doi: 10.1016/j.ijcard.2020.03.070. Int J Cardiol. 2020. PMID: 32505330 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

On interactions between body mass index, type of anticoagulation and outcomes

Affiliations

On interactions between body mass index, type of anticoagulation and outcomes

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical